Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer

Dr Don Dizon – Brown University, Providence, USA
Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer ( Dr Don Dizon – Brown University, Providence, USA )
19 Jun 2012

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )
19 Jun 2012

MEK inhibitor, trametinib, improves progression free survival in melanoma

Dr Caroline Robert – Institute Gustave Roussy, Paris, France
MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )
18 Jun 2012

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Dr Jean Yves-Blay - University Claude Bernard, Lyon, France
SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma ( Dr Jean Yves-Blay - University Claude Bernard, Lyon, France )
18 Jun 2012

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA
Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA )
18 Jun 2012

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA
Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )
18 Jun 2012

Novel PET tracers and their future use in assessment of response to treatment

Dr Andrei Iagaru – Stanford University, CA, USA
Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )
17 Jun 2012

Treating metastatic melanoma with vemurafenib

Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA
Treating metastatic melanoma with vemurafenib ( Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA
Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012

Role of family history and genetic testing in diagnosis

Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012

First line treatment against metastatic breast cancer

Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada
First line treatment against metastatic breast cancer ( Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada )
15 Jun 2012

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Dr Sagar Lonial – Emory University, Atlanta, USA
Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma ( Dr Sagar Lonial – Emory University, Atlanta, USA )
15 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation